Marinus Pharmaceuticals
Why Robinhood?
You can watch MRNS and buy or sell other stocks, ETFs, and their options commission-free!About MRNS
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.
MRNS Key Statistics
Stock Snapshot
Marinus Pharmaceuticals(MRNS) stock is priced at $0.55, giving the company a market capitalization of 29.63M. It carries a P/E multiple of -0.22.
During the trading day, Marinus Pharmaceuticals(MRNS) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 333.56K.
The stock's 52-week range extends from a low of $0.22 to a high of $10.50.
The stock's 52-week range extends from a low of $0.22 to a high of $10.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.